Dicerna™ to Present at Evercore ISI 2nd Annual HealthCONx Conference
Nov 26, 2019
A live audio webcast of the presentation will be accessible within the Investors & Media section on the Dicerna website at www.dicerna.com. An archived replay of the webcast will be available on the Company’s website after the conference.
* Transactions are subject to clearance under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 and other customary closing conditions.
Dicerna™ and GalXC™ are trademarks of
Stern Investor Relations, Inc.
Lauren Stival, 212-362-1200
Dicerna Pharmaceuticals, Inc.
Amy Trevvett, 617-612-6253
Alex Van Rees, 973-442-1555 ext. 111